期刊文献+

表达E2F1小干扰RNA的逆转录病毒载体的构建 被引量:5

Construction of recombinant retroviral vector expressing E2F1 short interference RNA
下载PDF
导出
摘要 目的 :建立一个表达E2F1小干扰RNA的靶向抑制E2F1表达的重组逆转录病毒载体。方法 :通过重组DNA技术 ,将设计好的两条互补寡核苷酸片段退火后与载体连接 ,利用载体上的BglⅡ和EcoRⅠ位点进行双酶切初步鉴定 ,重组载体应产生 3 3 2bp和 6182bp两个片段 ,选择酶切正确的重组载体进行测序 ,保证siRNA的方向和序列正确。结果 :表达siRNA的重组逆转录病毒载体构建成功。结论 :重组逆转录病毒载体的成功构建为下一步基因治疗的研究奠定了基础。 Objective To establish a recombinant retroviral vector expressing short interference RNA (siRNA) and targetedly suppressed E2F1 expression. Methods Using recombinant DNA techniques, 2 complementary 69bp oligonucleotides designed with hairpin loop for E2F1siRNA were annealed, and then inserted into the retrovirus expression vector pSIREN. Positive vectors were analyzed through digestion with BgL Ⅱ and EcoRⅠ, and obtained 2 fragments of 332bp and 6182bp by electrophoresion, and then DNA sequencing demonstrates the correct orientation and sequence. Results recombinant retroviral vector expressing short interference RNA (siRNA) had been constructed successfully.Conclusion Recominant retronral vertor may be used for further investigation of genetherapy.
出处 《实用诊断与治疗杂志》 2005年第3期177-179,181,共4页 Journal of Practical Diagnosis and Therapy
关键词 SIRNA 逆转录病毒载体 E2F1 Short interference RNA recombinant retroviral vector E2F1
  • 相关文献

参考文献18

  • 1Johnson D G,Schwarz J K,Cress W D, et al. Expression of transcription factor E2F1 induce squiescent cells to enter S phase[J]. Nature, 1993,365:349.
  • 2Sellers W R, Kaelin W G Jr. Role of the retinoblastoma protein in the pathogenesis of human cancer [J]. J Clin Oncol, 1997,15 :3301.
  • 3Suzuki T, Yasui W, Yokozaki H, et al. Expression of the E2F family in human gastrointestinal carcinomas [J]. Int J Cancer,1999,81:535.
  • 4Stanelle J, Stiewe T, Theseling C C, et al. Gene expression changes in response to E2F1 activition[J]. Nucleic Acides Res,2003,30(8) : 1859.
  • 5Kaelin W G Jr, Krek W, Sellers W R, et al. Expression cloning of a Cdna enclding a retinoblastoma-binding protein with E2F-like prpper ties [J]. Cell, 1992,70 : 351.
  • 6Shi Yu Zhang, Shao Chen Liu , Luma F, et al. E2FI: A proliferative marker of breast neoplasia[J]. Cancer EpidemiolBiomarkers Prey 2000,9(4) : 395.
  • 7Hammond S M, Bernstein E, Beach D, et al. An RNA-directed nuelease mediates post-transcriptional gene silencing in Drosophila cells[J]. Nature, 2000,404(6775):293.
  • 8Hart S, Park K, Bae B N, et al. E2F1 expression is related with the poor survival of lymph node-positive breast patients treated with fluorouracil, doxorubicin and cyclophosphamide[J]. Breast Cancer Res Treat, 2003, 82 : 11.
  • 9Ho G H, Calvano J E, Bisogna M,et al. Expression of E2F1and E2F4 is reduced in primary and metastatic breast caicinomas[J].Breast Cancer Res and Treat, 2001, 69 : 115.
  • 10Elbashir S M, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nueleotide RNAs[J], Genes Dev,2001,15(2):188

同被引文献44

  • 1尹家俊,胡祥,傅攀峰,袁晓东,张锦瑜.端粒酶逆转录酶基因启动子调控的肿瘤细胞特异表达载体的构建和鉴定[J].中华医学杂志,2003,83(14):1274-1277. 被引量:3
  • 2黄慧敏,李惠翔,张红,姜国忠,高冬玲,张岚.逆转录病毒载体介导的RNAi对MCF-7细胞E2F1 mRNA表达的影响[J].郑州大学学报(医学版),2005,40(5):804-806. 被引量:3
  • 3张怀军,李桑蕾,张磊,黄磊,邢新,李蠡.病理性瘢痕组织中E2F1基因的表达及其意义[J].实用诊断与治疗杂志,2007,21(3):187-189. 被引量:8
  • 4Sellers WR, Kaelin WG. Role of the retinoblastoma protein in the pathogenesis of human cancer[ J]. Clin Oneol, 1997, 15 ( 11 ) : 3301-4412.
  • 5Shi YZ, Shao CL, luma F,et al. E2FI: a proliferative marker of breast neoplasia [ J ]. Epidemiol Biomarkers Prey, 2000, 9 (4) : 395-401.
  • 6Li Q, Boyer C, Lee J, et al. A novel approach to thymidylate synthase as a target for cancer chemotherapy[ J ]. Mol Phar, 2001,59 (3) :446-452.
  • 7Han S, Park K, Bae BN, et al. E2F1 expression is related with the poor survival of lymph node-positive breast patients treated with fluorouracil, doxorubicin and cyclophosphamidereast[J]. Breast Cancer Res B Treat, 2003,82(1) :11-16.
  • 8Izqnierdo M. Short interfering RNAs as a tool for cancer gene therapy[J]. Cancer Gene Ther, 2005, 12(3) :217-227.
  • 9Chio J, Lira H, Nam DK, et al. Expression of thymidylate synthase in gastric cancer patients treated with 5-fluomuracil and doxorubicinbased adjuvant chemotherapy after curative resection[ J]. Br J Cancer ,2001,84(2) :186-192.
  • 10Vasavada R C, Gonzalez Pertusa J A, Fujinaka Y, et al. Growth factors and beta cell replication[J].Int J Biochcm Cell Biol,2006,38(5 6) :931-950.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部